NHS England hailed the deal that will make the “life-saving” therapy, called Libmeldy, available to the small number of babies and young children who have metachromatic leukodystrophy (MLD). Those who receive it will be able to enjoy a normal life, it said ...
from Google Alert - health https://ift.tt/5FqIrOe
via IFTTT
0 comments:
Post a Comment